{"public_metrics": {"retweet_count": 97, "reply_count": 42, "like_count": 156, "quote_count": 39}, "lang": "en", "possibly_sensitive": false, "entities": {"cashtags": [{"start": 191, "end": 196, "tag": "GILD"}], "annotations": [{"start": 0, "end": 14, "probability": 0.8285, "type": "Organization", "normalized_text": "Gilead Sciences"}], "urls": [{"start": 197, "end": 220, "url": "https://t.co/JXEvgyth9K", "expanded_url": "https://stories.gilead.com/articles/an-open-letter-from-daniel-oday-june-29", "display_url": "stories.gilead.com/articles/an-op\u2026"}]}, "source": "Twitter Web App", "text": "Gilead Sciences says it is pricing its remdesivir treatment, which could be used for Covid-19 patients, at $390 a vial. Typical patient needs 6 vials for 5 days. So that works out to $2,340. $GILD https://t.co/JXEvgyth9K", "reply_settings": "everyone", "conversation_id": "1277576376313356289", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "65", "name": "Interests and Hobbies Vertical", "description": "Top level interests and hobbies groupings, like Food or Travel"}, "entity": {"id": "781974596148793345", "name": "Business & finance"}}, {"domain": {"id": "66", "name": "Interests and Hobbies Category", "description": "A grouping of interests and hobbies entities, like Novelty Food or Destinations"}, "entity": {"id": "847888632711061504", "name": "Personal finance", "description": "Personal finance"}}, {"domain": {"id": "67", "name": "Interests and Hobbies", "description": "Interests, opinions, and behaviors of individuals, groups, or cultures; like Speciality Cooking or Theme Parks"}, "entity": {"id": "847894852779900928", "name": "Stocks & indices", "description": "Stocks"}}], "created_at": "2020-06-29T12:15:18.000Z", "id": "1277576376313356289", "author_id": "104952689"}